These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Imaging CXCR4 receptors expression for staging multiple myeloma by using Shekhawat AS; Singh B; Malhotra P; Watts A; Basher R; Kaur H; Hooda M; Radotra BD Br J Radiol; 2022 Aug; 95(1136):20211272. PubMed ID: 35731811 [TBL] [Abstract][Full Text] [Related]
3. Imaging Inflammation in Atherosclerosis with CXCR4-Directed Kircher M; Tran-Gia J; Kemmer L; Zhang X; Schirbel A; Werner RA; Buck AK; Wester HJ; Hacker M; Lapa C; Li X J Nucl Med; 2020 May; 61(5):751-756. PubMed ID: 31653710 [TBL] [Abstract][Full Text] [Related]
4. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients. Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856 [TBL] [Abstract][Full Text] [Related]
5. (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma. Lapa C; Lückerath K; Kleinlein I; Monoranu CM; Linsenmann T; Kessler AF; Rudelius M; Kropf S; Buck AK; Ernestus RI; Wester HJ; Löhr M; Herrmann K Theranostics; 2016; 6(3):428-34. PubMed ID: 26909116 [TBL] [Abstract][Full Text] [Related]
6. Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach. Werner RA; Weich A; Higuchi T; Schmid JS; Schirbel A; Lassmann M; Wild V; Rudelius M; Kudlich T; Herrmann K; Scheurlen M; Buck AK; Kropf S; Wester HJ; Lapa C Theranostics; 2017; 7(6):1489-1498. PubMed ID: 28529632 [TBL] [Abstract][Full Text] [Related]
7. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach. Linde P; Baues C; Wegen S; Trommer M; Quaas A; Rosenbrock J; Celik E; Marnitz S; Bruns CJ; Fischer T; Schomaecker K; Wester HJ; Drzezga A; van Heek L; Kobe C Cancer Imaging; 2021 Feb; 21(1):22. PubMed ID: 33579381 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of Kuyumcu S; Isik EG; Tiryaki TO; Has-Simsek D; Sanli Y; Buyukkaya F; Özkan ZG; Kalayoglu-Besisik S; Unal SN Ann Nucl Med; 2021 Oct; 35(10):1147-1156. PubMed ID: 34185263 [TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [ Kosmala A; Duell J; Schneid S; Serfling SE; Higuchi T; Weich A; Lapa C; Hartrampf PE; Raderer M; Einsele H; Buck AK; Topp MS; Schlötelburg W; Werner RA Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):749-755. PubMed ID: 37943339 [TBL] [Abstract][Full Text] [Related]
10. CXCR4-Directed PET/CT with [ Chen Z; Yang A; Zhang J; Chen A; Zhang Y; Huang C; Chen S; Yao S; Miao W Mol Imaging Biol; 2022 Jun; 24(3):416-424. PubMed ID: 34651291 [TBL] [Abstract][Full Text] [Related]
11. Luo Y; Cao X; Pan Q; Li J; Feng J; Li F J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745 [No Abstract] [Full Text] [Related]
12. [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience. Lapa C; Lückerath K; Rudelius M; Schmid JS; Schoene A; Schirbel A; Samnick S; Pelzer T; Buck AK; Kropf S; Wester HJ; Herrmann K Oncotarget; 2016 Feb; 7(8):9288-95. PubMed ID: 26843617 [TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor-4 targeted PET/CT with Pan Q; Cao X; Luo Y; Li J; Feng J; Li F Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631 [TBL] [Abstract][Full Text] [Related]
14. CXCR4 PET imaging of mantle cell lymphoma using [ Mayerhoefer ME; Raderer M; Lamm W; Pichler V; Pfaff S; Weber M; Kiesewetter B; Hacker M; Kazianka L; Staber PB; Wester HJ; Rohrbeck J; Simonitsch-Klupp I; Haug A Theranostics; 2021; 11(2):567-578. PubMed ID: 33391493 [TBL] [Abstract][Full Text] [Related]
18. Comparison of [ Liu M; Chen X; Ding H; Shu Q; Zheng Y; Chen Y; Cai L Mol Imaging Biol; 2024 Aug; 26(4):658-667. PubMed ID: 38627276 [TBL] [Abstract][Full Text] [Related]
19. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia. Luo Y; Pan Q; Feng J; Cao X; Li F Clin Nucl Med; 2018 Jul; 43(7):548-550. PubMed ID: 29742593 [TBL] [Abstract][Full Text] [Related]
20. Chemokine Receptor-4 Targeted PET/CT Imaging with Hadebe B; Harry L; Gabela L; Masikane S; Patel M; Zwane S; Pillay V; Bipath P; Cebekhulu N; Nyakale N; Ramdass P; Msimang M; Aldous C; Sathekge M; Vorster M Diagnostics (Basel); 2024 Jun; 14(13):. PubMed ID: 39001265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]